» Articles » PMID: 39841719

Female Brain and Endocrinological Research-Veteran (FemBER-Vet) Study: A Study Protocol for Identifying Endocrinological, Lifestyle and Psychosocial Determinants of Brain Health Outcomes in Female Veterans for Future Intervention Success

Overview
Journal PLoS One
Date 2025 Jan 22
PMID 39841719
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recent studies have demonstrated a greater risk of dementia in female veterans compared to civilians; with the highest prevalence noted for former service women with a diagnosis of psychiatric (trauma, alcoholism, depression), and/or a physical health condition (brain injury, insomnia, diabetes). Such findings highlight the need for increased and early screening of medical and psychiatric conditions, and indeed dementia, in the female veteran population. Further, they call for a better understanding of the underlying biopsychosocial mechanisms that might confer heightened risk for female veterans, to tailor preventative and interventional strategies that support brain health across the lifespan.

Methods: The Female Brain and Endocrinological Research-Veteran (FemBER-Vet) Study will create a highly-phenotyped readiness cohort of ex-service persons as well as non-veterans to assess the impacts of, and risks associated with, military service on brain health, using state-of-the-art non-invasive cognitive, physiological and biomarker capture techniques. FEMBER-Vet will include 90 participants across three study groups (30 female veterans, 30 male veterans, 30 female civilians) to delineate the precise biological, socio-demographic, health, lifestyle, military-related, and life-course determinants of brain health outcomes (psychosocial, cognitive, neurophysiological, and other biomarkers).

Discussion: This work addresses the poorly understood biopsychosocial outcomes that female veterans experience compared to their male counterparts and the general female population. Ultimately, it will provide evidence to support the development of tailored interventions for an emerging health priority that currently lacks sufficient evidence for screening and therapeutic intervention.

Citing Articles

Hormone replacement therapy, menopausal age and lifestyle variables are associated with better cognitive performance at follow-up but not cognition over time in older-adult women irrespective of APOE4 carrier status and co-morbidities.

Watermeyer T, Gregory S, Leetham E, Udeh-Momoh C, Muniz-Terrera G Front Dement. 2025; 3:1496051.

PMID: 39897117 PMC: 11782126. DOI: 10.3389/frdem.2024.1496051.

References
1.
Shansky R, Hamo C, Hof P, Lou W, McEwen B, Morrison J . Estrogen promotes stress sensitivity in a prefrontal cortex-amygdala pathway. Cereb Cortex. 2010; 20(11):2560-7. PMC: 2951843. DOI: 10.1093/cercor/bhq003. View

2.
Ziemann U, Rothwell J, Ridding M . Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol. 1996; 496 ( Pt 3):873-81. PMC: 1160871. DOI: 10.1113/jphysiol.1996.sp021734. View

3.
Donohue M, Sperling R, Salmon D, Rentz D, Raman R, Thomas R . The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol. 2014; 71(8):961-70. PMC: 4439182. DOI: 10.1001/jamaneurol.2014.803. View

4.
Yaffe K, Lwi S, Hoang T, Xia F, Barnes D, Maguen S . Military-related risk factors in female veterans and risk of dementia. Neurology. 2018; 92(3):e205-e211. PMC: 6340384. DOI: 10.1212/WNL.0000000000006778. View

5.
Murphy D, Turgoose D . Exploring patterns of alcohol misuse in treatment-seeking UK veterans: A cross-sectional study. Addict Behav. 2018; 92:14-19. DOI: 10.1016/j.addbeh.2018.11.044. View